Search

everythinglearnresearchcommunity

for

Search:↓

Polarized dermoscopy is slightly better than nonpolarized for diagnosing hair disorders, with each method having its own strengths.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Certain compounds from Panax ginseng can block proteins that affect hair growth, potentially helping treat hair loss.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Compounded topical minoxidil works better and is more tolerated than over-the-counter minoxidil for treating hair loss in Black women.

OCT can effectively examine and reveal details about human hair and scalp conditions.

Trps1 plays a key role in hair follicle development and cycling.

The woman's hair loss improved significantly with pharmacopuncture and needle-embedding therapy.

Red OLED therapy significantly boosts hair growth.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Botulinum and tetanus neurotoxins are better understood now, with updated information on their effects and treatment.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

New progesterone-based compounds can block male hormones.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Hemşire navigatör modeli, PKOS'lu kadınların tedaviye uyumunu ve yaşam kalitesini artırır.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

The woman's hair loss improved significantly after treatment with acupuncture, pharmacopuncture, and needle-embedding therapy.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Clascoterone may be a promising treatment for hair loss.